
Alembic Pharmaceuticals Limited – NSE:APLLTD.NS
Alembic Pharmaceuticals Limited stock price today
Alembic Pharmaceuticals Limited stock price monthly change
Alembic Pharmaceuticals Limited stock price quarterly change
Alembic Pharmaceuticals Limited stock price yearly change
Alembic Pharmaceuticals Limited key metrics
Market Cap | 205.44B |
Enterprise value | 215.71B |
P/E | 31.95 |
EV/Sales | 3.39 |
EV/EBITDA | 20.71 |
Price/Sales | 3.24 |
Price/Book | 4.22 |
PEG ratio | 0.91 |
EPS | 31.34 |
Revenue | 62.28B |
EBITDA | 9.57B |
Income | 6.15B |
Revenue Q/Q | 7.85% |
Revenue Y/Y | 10.19% |
Profit margin | 10.17% |
Oper. margin | 11.43% |
Gross margin | 59.36% |
EBIT margin | 11.43% |
EBITDA margin | 15.37% |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeAlembic Pharmaceuticals Limited stock price history
Alembic Pharmaceuticals Limited stock forecast
Alembic Pharmaceuticals Limited financial statements
Jun 2023 | 14.86B | 1.20B | 8.11% |
---|---|---|---|
Sep 2023 | 15.94B | 1.36B | 8.56% |
Dec 2023 | 16.30B | 1.80B | 11.07% |
Mar 2024 | 15.16B | 1.78B | 11.75% |
2026 | 77.44B | 8.57B | 11.08% |
---|---|---|---|
2027 | 86.26B | 11.16B | 12.94% |
Analysts Price target
Financials & Ratios estimates
Payout ratio | 0% |
---|
2016 | 0.58% |
---|---|
2017 | 0.76% |
2019 | 0.89% |
2020 | 3.24% |
2022 | 1.89% |
Jun 2023 | 0 | 0 | |
---|---|---|---|
Sep 2023 | 64552700000 | 19.85B | 30.75% |
Dec 2023 | 0 | 0 | |
Mar 2024 | 64455800000 | 16.27B | 25.25% |
Jun 2023 | 1.32B | 0 | 0 |
---|---|---|---|
Sep 2023 | 1.35B | 0 | 0 |
Dec 2023 | 1.38B | 0 | 0 |
Mar 2024 | 0 | 0 | 0 |
Alembic Pharmaceuticals Limited alternative data
Aug 2023 | 14,593 |
---|---|
Sep 2023 | 14,593 |
Oct 2023 | 14,593 |
Nov 2023 | 14,593 |
Dec 2023 | 14,593 |
Jan 2024 | 14,593 |
Feb 2024 | 14,593 |
Mar 2024 | 14,593 |
Apr 2024 | 14,593 |
May 2024 | 14,593 |
Jun 2024 | 14,593 |
Jul 2024 | 14,858 |
Alembic Pharmaceuticals Limited other data
Insider | Compensation |
---|---|
Mr. Chirayu Ramanbha Amin (1946) Executive Chairman & Chief Executive Officer | $315,000,000 |
Mr. Pranav Chirayu Amin (1975) MD & Executive Director | $220,000,000 |
Mr. Shaunak Chirayu Amin (1978) MD & Executive Director | $220,000,000 |
Mr. Raj Kumar Shreeram Baheti (1959) Director of Fin., Chief Financial Officer & Executive Director | $49,600,000 |
-
What's the price of Alembic Pharmaceuticals Limited stock today?
One share of Alembic Pharmaceuticals Limited stock can currently be purchased for approximately $808.
-
When is Alembic Pharmaceuticals Limited's next earnings date?
Unfortunately, Alembic Pharmaceuticals Limited's (APLLTD.NS) next earnings date is currently unknown.
-
Does Alembic Pharmaceuticals Limited pay dividends?
Yes, Alembic Pharmaceuticals Limited pays dividends and its trailing 12-month yield is 1.05% with 0% payout ratio. The last Alembic Pharmaceuticals Limited stock dividend of $0 was paid on 11 Sep 2025.
-
How much money does Alembic Pharmaceuticals Limited make?
Alembic Pharmaceuticals Limited has a market capitalization of 205.44B and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 19.05% to 62.29B US dollars.
-
What is Alembic Pharmaceuticals Limited's stock symbol?
Alembic Pharmaceuticals Limited is traded on the NSE under the ticker symbol "APLLTD.NS".
-
What is Alembic Pharmaceuticals Limited's primary industry?
Company operates in the Healthcare sector and Drug Manufacturers - Specialty & Generic industry.
-
How do i buy shares of Alembic Pharmaceuticals Limited?
Shares of Alembic Pharmaceuticals Limited can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are Alembic Pharmaceuticals Limited's key executives?
Alembic Pharmaceuticals Limited's management team includes the following people:
- Mr. Chirayu Ramanbha Amin Executive Chairman & Chief Executive Officer(age: 79, pay: $315,000,000)
- Mr. Pranav Chirayu Amin MD & Executive Director(age: 50, pay: $220,000,000)
- Mr. Shaunak Chirayu Amin MD & Executive Director(age: 47, pay: $220,000,000)
- Mr. Raj Kumar Shreeram Baheti Director of Fin., Chief Financial Officer & Executive Director(age: 66, pay: $49,600,000)
-
How many employees does Alembic Pharmaceuticals Limited have?
As Jul 2024, Alembic Pharmaceuticals Limited employs 14,858 workers, which is 2% more then previous month and 2% more then previous quarter.
-
When Alembic Pharmaceuticals Limited went public?
Alembic Pharmaceuticals Limited is publicly traded company for more then 13 years since IPO on 20 Sep 2011.
-
What is Alembic Pharmaceuticals Limited's official website?
The official website for Alembic Pharmaceuticals Limited is alembicpharmaceuticals.com.
-
How can i contact Alembic Pharmaceuticals Limited?
Alembic Pharmaceuticals Limited can be reached via phone at +91 265 228 0550.
Alembic Pharmaceuticals Limited company profile:

Alembic Pharmaceuticals Limited
alembicpharmaceuticals.comNSE
14,858
Drug Manufacturers - Specialty & Generic
Healthcare
Alembic Pharmaceuticals Limited develops, manufactures, and markets pharmaceutical products in India and internationally. It offers active pharmaceutical ingredients and formulations. The company also provides branded and generic formulations in various therapeutic areas, such as cardiology, gynecology, gastrology, ophthalmology, dermatology, nephrology/urology, orthopedics, anti-infective, cold and cough, and anti-diabetic. In addition, it exports its products. Alembic Pharmaceuticals Limited was founded in 1907 and is headquartered in Vadodara, India.
Vadodara, 390003
:
ISIN: INE901L01018
CUSIP: Y0R76F109